基层与社区多病共存管理干预效果的系统综述与Meta分析
该研究系统检索截至2024年9月30日的文献,纳入33项研究(Meta分析26项、9449名参与者),评估药物管理、自我管理支持及照护协调联合自我管理支持对成人多病共存患者的干预效果。总体与常规照护相比多数结局获益证据有限,但自我管理支持与照护协调联合自我管理支持在住院风险和部分健康结局上显示一定改善信号,卫生经济学证据仍匮乏。
要点
- 自我管理支持与较低住院风险和较低药物费用相关,但急诊就诊略增。
- 照护协调联合自我管理支持与更好SF-12 PCS评分、较低住院风险和较少急诊就诊相关,但门诊和全科就诊增多。
- 多数结局与常规照护相比无显著获益,卫生经济学证据尤其不足。
核心结论
- 总体而言,与常规照护相比,多病共存管理干预在多数结局上无显著获益证据。
- 自我管理支持及照护协调联合自我管理支持在部分结局和医疗利用上显示改善信号。
- 报告健康结局尤其医疗费用的证据仍然匮乏。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE、CINAHL、Cochrane Library、两个试验注册库及灰色文献至2024年9月30日。
- 纳入在基层或社区照护环境中接受照护的成人多病共存研究,由两名评价者独立筛选、提取数据并评估偏倚风险和研究确定性。
主要发现
- 自我管理支持与较低住院风险和较低药物费用相关,但急诊就诊略多。
- 照护协调联合自我管理支持与更好SF-12 PCS评分、较低住院风险和较少急诊就诊相关,但门诊和全科医生就诊更多。
- 总体与常规照护相比,多数结局无显著获益证据。
关键数值与推荐
- 多病共存定义为同一个体存在两种或以上慢性健康状况,不参照索引疾病。
- 干预分为药物管理、自我管理支持、照护协调联合自我管理支持三类。
- 主要结局为健康相关生活质量、医疗利用和医疗费用。
临床怎么用
- 在基层与社区管理中,可考虑对多病共存患者提供自我管理支持,但需关注急诊就诊可能略增。
- 照护协调联合自我管理支持可能改善躯体健康评分并减少住院和急诊就诊,但可能增加门诊和全科就诊。
- 决策时应认识到多数结局获益证据有限且卫生经济学证据不足。
局限性
- 报告健康结局尤其医疗费用的证据匮乏。
- 多数结局与常规照护相比无显著获益证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multimorbidity-the co-existence of two or more chronic health conditions in the same individual, without reference to an index condition-has become a global health issue and creates enormous pressure on the healthcare system. This review aimed to summarize evidence on the effectiveness of interventions used to manage people with multimorbidity. METHODS: MEDLINE, EMBASE, CINAHL, Cochrane Library, two trials registers, and grey literature were searched for studies of adults with multimorbidity receiving care in primary or community care settings up to 30 September 2024. Two reviewers independently screened studies for eligibility, extracted data, and assessed risk of bias and study certainty. Interventions were categorized as medicines management (MM), support for self-management (SSM), or care coordination plus support for self-management (CC + SSM). Meta-analyses for primary outcomes (health-related quality of life, healthcare utilization, and healthcare costs) were conducted. RESULTS: From 10 272 titles screened, 33 eligible studies (this review: 18, previous review: 15; MM: 6, SSM: 9, CC + SSM: 18) were identified, of which 26 studies with 9449 participants were included in meta-analysis. Overall, there was little significant evidence of benefit of the interventions compared with usual care for most outcomes. SSM was associated with lower hospitalization risk and medication costs, but slightly more emergency department (ED) visits; and CC + SSM with better SF-12 PCS score, lower hospitalization risk and fewer ED visits, but more outpatient and general practitioner visits. CONCLUSION: This review found some suggestions of improved outcomes and reduced healthcare utilization (especially hospitalization) for these interventions. There is a paucity of evidence reporting on health outcomes, especially healthcare costs, in the management of multimorbidity.
引用
- Lim YW, Al-Busaidi IS, Caya R, et al. Effectiveness of interventions for the management of multimorbidity in primary care and community settings: systematic review and meta-analysis. Fam Pract. 2025. PMID: 41215648. doi:10.1093/fampra/cmaf085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。